Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs
Our findings suggest that the risk of incident DIILD depends on the category of anti-neoplastic drugs. Patients with identified risk factors and treated with these drugs should be monitored closely.
Authors
- Il-Hyung Hwang
- Seung Hyeun Lee (ORCID: https://orcid.org/0000-0002-7666-313X)
- Hankil Lee (ORCID: https://orcid.org/0000-0002-7780-159X)
Institutions
- Ewha Womans University (KR)
- Kyung Hee University (KR)
- Ewha Womans University Medical Center (KR)
- Ajou University (KR)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1080/14740338.2025.2472918
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Food and Drug Safety